nach oben

Erschienen in:

07.05.2016 | Original Article

Modified tricalcium silicate cement formulations with added zirconium oxide

verfasst von: Xin Li, Kumiko Yoshihara, Jan De Munck, Stevan Cokic, Pong Pongprueksa, Eveline Putzeys, Mariano Pedano, Zhi Chen, Kirsten Van Landuyt, Bart Van Meerbeek

Erschienen in: Clinical Oral Investigations | Ausgabe 3/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

This study aims to investigate the effect of modifying tricalcium silicate (TCS) cements on three key properties by adding ZrO₂.

Materials and methods

TCS powders were prepared by adding ZrO₂ at six different concentrations. The powders were mixed with 1 M CaCl₂ solution at a 3:1 weight ratio. Biodentine (contains 5 wt.% ZrO₂) served as control. To evaluate the potential effect on mechanical properties, the mini-fracture toughness (mini-FT) was measured. Regarding bioactivity, Ca release was assessed using ICP-AES. The component distribution within the cement matrix was evaluated by Feg-SEM/EPMA. Cytotoxicity was assessed using an XTT assay.

Results

Adding ZrO₂ to TCS did not alter the mini-FT (p = 0.52), which remained in range of that of Biodentine (p = 0.31). Ca release from TSC cements was slightly lower than that from Biodentine at 1 day (p > 0.05). After 1 week, Ca release from TCS 30 and TCS 50 increased to a level that was significantly higher than that from Biodentine (p < 0.05). After 1 month, Ca release all decreased (p < 0.05), yet TCS 0 and TCS 50 released comparable amounts of Ca as at 1 day (p > 0.05). EPMA revealed a more even distribution of ZrO₂ within the TCS cements. Particles with an un-reacted core were surrounded by a hydration zone. The 24-, 48-, and 72-h extracts of TCS 50 were the least cytotoxic.

Conclusions

ZrO₂ can be added to TCS without affecting the mini-FT; Ca release was reduced initially, to reach a prolonged release thereafter; adding ZrO₂ made TCS cements more biocompatible.

Clinical relevance

TCS 50 is a promising cement formulation to serve as a biocompatible hydraulic calcium silicate cement.

Torabinejad M, Chivian N (1999) Clinical applications of mineral trioxide aggregate. J Endod 25:197–205CrossRefPubMed

Parirokh M, Torabinejad M (2010) Mineral trioxide aggregate: a comprehensive literature review—part III: clinical applications, drawbacks, and mechanism of action. J Endod 36:400–403. doi:10.1016/j.joen.2009.09.009 CrossRefPubMed

Qi YP, Li N, Niu LN, Primus CM, Ling JQ, Pashley DH, Tay FR (2012) Remineralization of artificial dentinal caries lesions by biomimetically modified mineral trioxide aggregate. Acta Biomater 8:836–842. doi:10.1016/j.actbio.2011.10.033 CrossRefPubMed

Bozeman TB, Lemon RR, Eleazer PD (2006) Elemental analysis of crystal precipitate from gray and white MTA. J Endod 32:425–428CrossRefPubMed

Gandolfi MG, Taddei P, Siboni F, Modena E, Ciapetti G, Prati C (2011) Development of the foremost light-curable calcium-silicate MTA cement as root-end in oral surgery. Chemical-physical properties, bioactivity and biological behavior. Dent Mater 27:e134–e157. doi:10.1016/j.dental.2011.03.011 CrossRefPubMed

Camilleri J, Sorrentino F, Damidot D (2013) Investigation of the hydration and bioactivity of radiopacified tricalcium silicate cement, Biodentine and MTA Angelus. Dent Mater 29:580–593. doi:10.1016/j.dental.2013.03.007 CrossRefPubMed

Niu LN, Jiao K, Wang TD, Zhang W, Camilleri J, Bergeron BE, Feng HL, Mao J, Chen JH, Pashley DH, Tay FR (2014) A review of the bioactivity of hydraulic calcium silicate cements. J Dent 42:517–533. doi:10.1016/j.jdent.2013.12.015 CrossRefPubMedPubMedCentral

Prati C, Gandolfi MG (2015) Calcium silicate bioactive cements: biological perspectives and clinical applications. Dent Mater 31:351–370. doi:10.1016/j.dental.2015.01.004 CrossRefPubMed

Chen Z, Cao S, Wang H, Li Y, Kishen A, Deng X, Yang X, Wang Y, Cong C, Wang H, Zhang X (2015) Biomimetic remineralization of demineralized dentine using scaffold of CMC/ACP nanocomplexes in an in vitro tooth model of deep caries. PLoS One 14:e0116553. doi:10.1371/journal.pone.0116553 CrossRef

10.

Gandolfi MG, Taddei P, Siboni F, Modena E, De Stefano ED, Prati C (2011) Biomimetic remineralization of human dentin using promising innovative calcium-silicate hybrid “smart” materials. Dent Mater 27:1055–1069. doi:10.1016/j.dental.2011.07.007 CrossRefPubMed

11.

Camilleri J, Montesin FE, Brady K, Sweeney R, Curtis RV, Ford TR (2005) The constitution of mineral trioxide aggregate. Dent Mater 21:297–303CrossRefPubMed

12.

Schembri M, Peplow G, Camilleri J (2010) Analyses of heavy metals in mineral trioxide aggregate and Portland cement. J Endod 36:1210–1215. doi:10.1016/j.joen.2010.02.011 CrossRefPubMed

13.

Monteiro Bramante C, Demarchi AC, de Moraes IG, Bernadineli N, Garcia RB, Spangberg LS, Duarte MA (2008) Presence of arsenic in different types of MTA and white and gray Portland cement. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106:909–913. doi:10.1016/j.tripleo.2008.07.018 CrossRefPubMed

14.

Camilleri J (2011) Characterization and hydration kinetics of tricalcium silicate cement for use as a dental biomaterial. Dent Mater 27:836–844. doi:10.1016/j.dental.2011.04.010 CrossRefPubMed

15.

Chen CC, Ho CC, David Chen CH, Ding SJ (2009) Physicochemical properties of calcium silicate cements for endodontic treatment. J Endod 35:1288–1291. doi:10.1016/j.joen.2009.05.036 CrossRefPubMed

16.

Dong Z, Chang J, Deng Y, Joiner A (2011) Tricalcium silicate induced mineralization for occlusion of dentinal tubules. Aust Dent J 56:175–180. doi:10.1111/j.1834-7819.2011.01321.x CrossRefPubMed

17.

Zhao W, Wang J, Zhai W, Wang Z, Chang J (2005) The self-setting properties and in vitro bioactivity of tricalcium silicate. Biomaterials 26:6113–6121CrossRefPubMed

18.

Corral Nunez CM, Bosomworth HJ, Field C, Whitworth JM, Valentine RA (2014) Biodentine and mineral trioxide aggregate induce similar cellular responses in a fibroblast cell line. J Endod 40:406–411. doi:10.1016/j.joen.2013.11.006 CrossRefPubMed

19.

Jang YE, Lee BN, Koh JT, Park YJ, Joo NE, Chang HS, Hwang IN, Oh WM, Hwang YC (2014) Cytotoxicity and physical properties of tricalcium silicate-based endodontic materials. Restor Dent Endod 39:89–94. doi:10.5395/rde.2014.39.2.89 CrossRefPubMedPubMedCentral

20.

Tran XV, Gorin C, Willig C, Baroukh B, Pellat B, Decup F, Opsahl Vital S, Chaussain C, Boukpessi T (2012) Effect of a calcium-silicate-based restorative cement on pulp repair. J Dent Res 91:1166–1171. doi:10.1177/0022034512460833 CrossRefPubMed

21.

Song JS, Mante FK, Romanow WJ, Kim S (2006) Chemical analysis of powder and set forms of Portland cement, gray ProRoot MTA, white ProRoot MTA, and gray MTA-Angelus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 102:809–815CrossRefPubMed

22.

Coomaraswamy KS, Lumley PJ, Hofmann MP (2007) Effect of bismuth oxide radioopacifier content on the material properties of an endodontic Portland cement-based (MTA-like) system. J Endod 33:295–298CrossRefPubMed

23.

Antonijevic D, Medigovic I, Zrilic M, Jokic B, Vukovic Z, Todorovic L (2014) The influence of different radiopacifying agents on the radiopacity, compressive strength, setting time, and porosity of Portland cement. Clin Oral Investig 18:1597–1604CrossRefPubMed

24.

Hungaro Duarte MA, Minotti PG, Rodrigues CT, Zapata RO, Bramante CM, Tanomaru Filho M, Vivan RR, Gomes de Moraes I, Bombarda de Andrade F (2012) Effect of different radiopacifying agents on the physicochemical properties of white Portland cement and white mineral trioxide aggregate. J Endod 38:394–397. doi:10.1016/j.joen.2011.11.005 CrossRefPubMed

25.

Camilleri J, Montesin FE, Papaioannou S, McDonald F, Pitt Ford TR (2004) Biocompatibility of two commercial forms of mineral trioxide aggregate. Int Endod J 37:699–704CrossRefPubMed

26.

Gomes Cornelio AL, Salles LP, Campos da Paz M, Cirelli JA, Guerreiro-Tanomaru JM, Tanomaru Filho M (2011) Cytotoxicity of Portland cement with different radiopacifying agents: a cell death study. J Endod 37:203–210. doi:10.1016/j.joen.2010.11.017 CrossRefPubMed

27.

Marciano MA, Costa RM, Camilleri J, Mondelli RF, Guimaraes BM, Duarte MA (2014) Assessment of color stability of white mineral trioxide aggregate angelus and bismuth oxide in contact with tooth structure. J Endod 40:1235–1240. doi:10.1016/j.joen.2014.01.044 CrossRefPubMed

28.

Camilleri J, Cutajar A, Mallia B (2011) Hydration characteristics of zirconium oxide replaced Portland cement for use as a root-end filling material. Dent Mater 27:845–854. doi:10.1016/j.dental.2011.04.011 CrossRefPubMed

29.

Guerreiro Tanomaru JM, Storto I, Da Silva GF, Bosso R, Costa BC, Bernardi MI, Tanomaru-Filho M (2014) Radiopacity, pH and antimicrobial activity of Portland cement associated with micro- and nanoparticles of zirconium oxide and niobium oxide. Dent Mater J 33:466–470CrossRefPubMed

30.

Hungaro Duarte MA, de Oliveira El Kadre GD, Vivan RR, Guerreiro Tanomaru JM, Tanomaru Filho M, de Moraes IG (2009) Radiopacity of Portland cement associated with different radiopacifying agents. J Endod 35:737–740. doi:10.1016/j.joen.2009.02.006 CrossRefPubMed

31.

Cutajar A, Mallia B, Abela S, Camilleri J (2011) Replacement of radiopacifier in mineral trioxide aggregate; characterization and determination of physical properties. Dent Mater 27:879–891. doi:10.1016/j.dental.2011.04.012 CrossRefPubMed

32.

Li Q, Deacon AD, Coleman NJ (2013) The impact of zirconium oxide nanoparticles on the hydration chemistry and biocompatibility of white Portland cement. Dent Mater J 32:808–815CrossRefPubMed

33.

Silva GF, Tanomaru-Filho M, Bernardi MI, Guerreiro-Tanomaru JM, Cerri PS (2015) Niobium pentoxide as radiopacifying agent of calcium silicate-based material: evaluation of physicochemical and biological properties. Clin Oral Investig 19:2015–2025. doi:10.1007/s00784-015-1412-9 CrossRefPubMed

34.

Silva GF, Bosso R, Ferino RV, Tanomaru-Filho M, Bernardi MI, Guerreiro-Tanomaru JM, Cerri PS (2014) Microparticulated and nanoparticulated zirconium oxide added to calcium silicate cement: evaluation of physicochemical and biological properties. J Biomed Mater Res A 102:4336–4345. doi:10.1002/jbm.a.35099 CrossRefPubMed

35.

Zhang J, Liu W, Schnitzler V, Tancret F, Bouler JM (2014) Calcium phosphate cements for bone substitution: chemistry, handling and mechanical properties. Acta Biomater 10:1035–1049. doi:10.1016/j.actbio.2013.11.001 CrossRefPubMed

36.

Wan D, Bao Y, Peng J, Zhou Y (2009) Fracture toughness determination of Ti₃Si(Al)C₂ and Al₂O₃ using a single gradient notched beam (SGNB) method. J Eur Cera Soc 29:763–771. doi:10.1016/j.jeurceramsoc.2008.06.031 CrossRef

37.

Pongprueksa P, De Munck J, Karunratanakul K, Barreto BC, Van Ende A, Senawongse P, Van Meerbeek B (2016) Dentin bonding testing using a mini-interfacial fracture toughness approach. J Dent Res 95:327–333

38.

Gandolfi MG, Siboni F, Prati C (2012) Chemical-physical properties of TheraCal, a novel light-curable MTA-like material for pulp capping. Int Endod J 45:571–579. doi:10.1111/j.1365-2591.2012.02013.x CrossRefPubMed

39.

Camilleri J, Kralj P, Veber M, Sinagra E (2012) Characterization and analyses of acid-extractable and leached trace elements in dental cements. Int Endod J 45:737–743. doi:10.1111/j.1365-2591.2012.02027.x CrossRefPubMed

40.

Poggio C, Arciola CR, Beltrami R, Monaco A, Dagna A, Lombardini M, Visai L (2014) Cytocompatibility and antibacterial properties of capping materials. Scientific World J 2014:181945. doi:10.1155/2014/181945 CrossRef

41.

Caughman WF, Caughman GB, Shiflett RA, Rueggeberg F, Schuster GS (1991) Correlation of cytotoxicity, filler loading and curing time of dental composites. Biomaterials 12:737–740CrossRefPubMed

42.

Stanislawski L, Daniau X, Lauti A, Goldberg M (1999) Factors responsible for pulp cell cytotoxicity induced by resin-modified glass ionomer cements. J Biomed Mater Res 48:277–288CrossRefPubMed

43.

Schröder U (1985) Effects of calcium hydroxide-containing pulp-capping agents on pulp cell migration, proliferation, and differentiation. J Dent Res 64 Spec No:541–8

44.

Cvek M (1978) A clinical report on partial pulpotomy and capping with calcium hydroxide in permanent incisors with complicated crown fracture. J Endod 4:232–237CrossRefPubMed

45.

Min KS, Kim HI, Park HJ, Pi SH, Hong CU, Kim EC (2007) Human pulp cells response to Portland cement in vitro. J Endod 33:163–166CrossRefPubMed

46.

Furey A, Hjelmhaug J, Lobner D (2010) Toxicity of flow line, Durafill VS, and Dycal to dental pulp cells: effects of growth factors. J Endod 36:1149–1153. doi:10.1016/j.joen.2010.03.013 CrossRefPubMedPubMedCentral

47.

Hirschman WR, Wheater MA, Bringas JS, Hoen MM (2012) Cytotoxicity comparison of three current direct pulp-capping agents with a new bioceramic root repair putty. J Endod 38:385–388. doi:10.1016/j.joen.2011.11.012 CrossRefPubMed

Titel: Modified tricalcium silicate cement formulations with added zirconium oxide
verfasst von: Xin Li
Kumiko Yoshihara
Jan De Munck
Stevan Cokic
Pong Pongprueksa
Eveline Putzeys
Mariano Pedano
Zhi Chen
Kirsten Van Landuyt
Bart Van Meerbeek
Publikationsdatum: 07.05.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Clinical Oral Investigations / Ausgabe 3/2017
Print ISSN: 1432-6981
Elektronische ISSN: 1436-3771
DOI: https://doi.org/10.1007/s00784-016-1843-y

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

19.04.2024 Vorhofflimmern Nachrichten

Werden Personen mit Vorhofflimmern in der Blanking-Periode nach einer Katheterablation gegen eine bestehende Parodontitis behandelt, verbessert dies die Erfolgsaussichten. Dafür sprechen die Resultate einer prospektiven Untersuchung.

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

11.04.2024 Endokarditis Nachrichten

Bei welchen Personen eine Antibiotikaprophylaxe zur Prävention einer infektiösen Endokarditis nach invasiven zahnärztlichen Eingriffen sinnvoll ist, wird diskutiert. Neue Daten stehen im Einklang mit den europäischen Leitlinienempfehlungen.

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

08.04.2024 Zahnmedizin Nachrichten

Der Aufbau von Geweben und Organen während der Embryonalentwicklung wird von den Zellen bemerkenswert choreografiert. Für diesen Prozess braucht es spezielle sogenannte „Organisatoren“. In einer aktuellen Veröffentlichung im Fachjournal Nature Cell Biology berichten Forschende durch welchen Vorgang diese Organisatoren im Gewebe entstehen und wie sie dann die Bildung von Zähnen orchestrieren.

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

11.03.2024 Kinderzahnmedizin Nachrichten

Infolge der Umbenennung der Deutschen Gesellschaft für Kinderzahnheilkunde in Deutsche Gesellschaft für Kinderzahnmedizin (DGKiZ) wird deren Mitgliederzeitschrift Oralprophylaxe & Kinderzahnheilkunde in Oralprophylaxe & Kinderzahnmedizin umbenannt. Aus diesem Grunde trägt die erste Ausgabe in 2024 erstmalig den neuen Titel.

Bestellen Sie unseren kostenlosen Newsletter Update Zahnmedizin und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Abstract

Objectives

Materials and methods

Results

Conclusions

Clinical relevance

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2017

Longevity and associated risk factors in adhesive restorations of young permanent teeth after complete and selective caries removal: a retrospective study

Responsiveness of the Prosthetic Esthetic Scale

Ultrasonic activation of irrigants increases growth factor release from human dentine

Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?

Soft tissue coverage on the segmentation accuracy of the 3D surface-rendered model from cone-beam CT

Efficacy of calcium oxide and calcium hydroxide nanoparticles on the elimination of Enterococcus faecalis in human root dentin

Neu im Fachgebiet Zahnmedizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Invasive Zahnbehandlung: Wann eine Antibiotikaprophylaxe vor infektiöser Endokarditis schützt

Zell-Organisatoren unter Druck: Mechanismen des embryonalen Zahnwachstums aufgedeckt

Die Oralprophylaxe & Kinderzahnheilkunde umbenannt

Newsletter